Neither T-helper type 2 nor Foxp3+regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
Weber, Martin S, Prod’homme, Thomas, Youssef, Sawsan, Dunn, Shannon E, Steinman, Lawrence, Zamvil, Scott SVolume:
11
Language:
english
Journal:
Journal of Neuroinflammation
DOI:
10.1186/1742-2094-11-29
Date:
December, 2014
File:
PDF, 1.22 MB
english, 2014